On-Demand Webinars

31. Less Risk, More Speed -The New Blueprint For Bioconjugate Development 4/15/2026

    A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.

32. Formulating The Future: A Practical Guide To Nucleic Acid Therapeutics 4/14/2026

    An expert-led webinar exploring nucleic acid therapeutic modalities, delivery systems, formulation challenges, and real-world case studies shaping drug product development.

33. ADC Payloader-Linker CMC Process Development Strategy 4/13/2026

    Shows how payload‑linker CMC planning differs from clinical to commercial, what drives route and RSM decisions, and how QC shifts from release testing to CQA‑linked specs, illustrated with IND vs NDA.

34. HPAPIS Production: "Where Micrograms Matters" 4/13/2026

    In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.

35. From Bench To Approval: Smart IVBE Strategies For Complex Drugs 4/10/2026

    In vitro bioequivalence can replace clinical studies for complex products when well designed. Clinically relevant, risk-based methods under realistic conditions show site-of-action equivalence.

36. From Fermentation To Vaccination 4/8/2026

    Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.

37. From Clinical To Commercial: Introducing Devices Earlier To Streamline The DDC Journey 4/8/2026

    Uncover how early device strategy and integrated planning can streamline development, reduce risk, and accelerate your path to commercial success.

38. Unlocking The Benefits Of Customs Warehouse For Pharmaceutical Supply Chains 4/8/2026

    Learn how leveraging a customs warehouse can streamline your supply chain, reduce VAT costs, and enhance global compliance and efficiency.

39. Global Manufacturing Excellence Across Quality, Efficiency, And Cost Of Goods Sold 3/26/2026

    Learn strategies to strengthen global biologics manufacturing through consistent quality, advanced technologies, and efficient tech transfer to improve operations and commercial readiness.

40. Ensure Successful Viral Clearance 3/26/2026

    A decade of viral clearance data comparing established and emerging operations, highlighting LRV performance, key process risks, and practical insights to strengthen downstream safety.